Nuvalent (NUVL) EPS (Basic) (2020 - 2026)

Nuvalent's (NUVL) quarterly EPS (Basic) came in at -$1.39 in Q1 2026, down 17.6% YoY from -$1.69 in Q1 2025, and down 249.2% on a QoQ basis from -$0.4 in Q4 2025.

Nuvalent (NUVL) EPS (Basic) (2020 - 2026) Analysis & Trends

Nuvalent (NUVL) has 7 years of EPS (Basic) data on file, last reported at -$1.39 in Q1 2026.

  • Quarterly EPS (Basic) fell 17.6% year-over-year to -$1.39 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.58 (down 9.0% YoY) and the FY2025 annual result came in at -$4.62, down 17.58% from the prior year.
  • EPS (Basic) declined to -$1.39 in Q1 2026, from -$0.4 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.38 in Q1 2022 to a low of -$1.7 in Q3 2025.
  • A 5-year average of -$0.82 and a median of -$0.66 in 2023 frame the typical range for EPS (Basic).
  • Annual changes were most pronounced in 2022 — EPS (Basic) surged 87.21% — and 2024, when it tumbled 117.91%.
  • Tracing NUVL's EPS (Basic) over 5 years: stood at -$0.55 in 2022, then declined by 18.95% to -$0.66 in 2023, then plunged by 71.18% to -$1.13 in 2024, then soared by 64.67% to -$0.4 in 2025, then plunged by 249.2% to -$1.39 in 2026.
  • The last three EPS (Basic) figures came in at -$1.39 (Q1 2026), -$0.4 (Q4 2025), and -$1.7 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.62
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.59
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.18
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.23
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Nuvalent 9.10 Bn 9.10 Bn - -1.39

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.39
Dec 31, 2025 -0.40
Sep 30, 2025 -1.70
Jun 30, 2025 -1.39
Mar 31, 2025 -1.18
Dec 31, 2024 -1.13
Sep 30, 2024 -1.28
Jun 30, 2024 -0.88
Mar 31, 2024 -0.69
Dec 31, 2023 -0.66
Sep 30, 2023 -0.59
Jun 30, 2023 -0.51
Mar 31, 2023 -0.44
Dec 31, 2022 -0.55
Sep 30, 2022 -0.43
Jun 30, 2022 -0.41
Mar 31, 2022 -0.38
Dec 31, 2021 -1.87
Sep 30, 2021 -0.39
Jun 30, 2021 -3.17